Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Aymen Rabai"'
Autor:
Aymen Rabai, Léa Reisser, Bernardo Reina-San-Martin, Kamel Mamchaoui, Belinda S. Cowling, Anne-Sophie Nicot, Jocelyn Laporte
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 16, Iss , Pp 246-256 (2019)
Genome editing with the CRISPR/Cas9 technology has emerged recently as a potential strategy for therapy in genetic diseases. For dominant mutations linked to gain-of-function effects, allele-specific correction may be the most suitable approach. In t
Externí odkaz:
https://doaj.org/article/b5c577217cec4392a10bdd1efa8ff7c4
Autor:
Delphine Trochet, Bernard Prudhon, Maud Beuvin, Cécile Peccate, Stéphanie Lorain, Laura Julien, Sofia Benkhelifa‐Ziyyat, Aymen Rabai, Kamel Mamchaoui, Arnaud Ferry, Jocelyn Laporte, Pascale Guicheney, Stéphane Vassilopoulos, Marc Bitoun
Publikováno v:
EMBO Molecular Medicine, Vol 10, Iss 2, Pp 239-253 (2017)
Abstract Rapid advances in allele‐specific silencing by RNA interference established a strategy of choice to cure dominant inherited diseases by targeting mutant alleles. We used this strategy for autosomal‐dominant centronuclear myopathy (CNM),
Externí odkaz:
https://doaj.org/article/a4426586b535417d812fa75336f2413c
Autor:
Kamel Mamchaoui, Léa Reisser, Bernardo Reina-San-Martin, Aymen Rabai, Jocelyn Laporte, Anne-Sophie Nicot, Belinda S. Cowling
Publikováno v:
Molecular Therapy-Nucleic Acids
Molecular Therapy-Nucleic Acids, Elsevier, 2019, ⟨10.1016/j.omtn.2019.02.019⟩
Molecular Therapy: Nucleic Acids, Vol 16, Iss, Pp 246-256 (2019)
Molecular Therapy-Nucleic Acids, 2019, ⟨10.1016/j.omtn.2019.02.019⟩
Molecular Therapy. Nucleic Acids
Molecular Therapy-Nucleic Acids, Elsevier, 2019, ⟨10.1016/j.omtn.2019.02.019⟩
Molecular Therapy: Nucleic Acids, Vol 16, Iss, Pp 246-256 (2019)
Molecular Therapy-Nucleic Acids, 2019, ⟨10.1016/j.omtn.2019.02.019⟩
Molecular Therapy. Nucleic Acids
Genome editing with the CRISPR/Cas9 technology has emerged recently as a potential strategy for therapy in genetic diseases. For dominant mutations linked to gain-of-function effects, allele-specific correction may be the most suitable approach. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd02d398d8c660af101e6fe665182ce4
https://hal.archives-ouvertes.fr/hal-02438235/document
https://hal.archives-ouvertes.fr/hal-02438235/document
Autor:
Aurélien Roux, Ivana Prokic, Belinda S. Cowling, Frédéric Humbert, Anne-Sophie Nicot, Hichem Tasfaout, Christine Kretz, Bruno Rinaldi, Aymen Rabai, Jocelyn Laporte, Sylvie Friant
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, American Society for Clinical Investigation, 2017, 127 (12), pp.4477-4487. ⟨10.1172/JCI90542⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2017, 127 (12), pp.4477-4487. ⟨10.1172/JCI90542⟩
International audience; Regulation of skeletal muscle development and organization is a complex process that is not fully understood. Here, we focused on amphiphysin 2 (BIN1, also known as bridging integrator-1) and dynamin 2 (DNM2), two ubiquitous p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b4eb48bb06f3d6c64d87be532f547a6b
https://hal.archives-ouvertes.fr/hal-02378704
https://hal.archives-ouvertes.fr/hal-02378704